When: Tuesday September 28, 2021
Where: RSA, London and online

Did you know that retail sales of CBD in the UK are set to reach $1billion this year? This makes it comfortably the second largest market for consumer cannabinoids worldwide, only eclipsed by the US. 

In this special event, hosted by The Association for the Cannabinoid Industry (ACI), provided businesses with the essential information they require to enter the UK market. 

ACI is the UK’s premier organisation supporting legally regulated cannabinoid companies in the UK. Over the course of the last year our team of unrivaled experts and partners have helped businesses like yours from the US, Canada, the EU, South America and Australia to navigate the complex regulatory and logistical challenges of entering the UK market. 

On 28th September we hosted a ‘hybrid’ event –  UK-CBD – Accessing the Billion Dollar British Cannabinoid Market – at the RSA in London.


Welcome introduction | Steve Moore, Lead Counsel and Founder, ACI

CBD Consumer Insight | Tom Mitchell, Director, Kantar

Regulatory application support | Laura Williamson, Membership Manager, ACI

Toxicological data | Dr Parveen Bhatarah, Head of Regulatory and Compliance Associate, ACI

Legal support | Dr Beatriz San Martin, Partner, Arnold & Porter 

Strategic communications support | Richard Clarke,  Managing Director, Ingredients Communications 

Attendees left the event with a clear understanding of how the ACI can ensure they 

  1. Submit the scientific dossiers for market authorisation in the UK (and EU)
  2. Access the mandated toxicological data to support successful Novel Foods applications
  3. Recruit the best team to drive your UK operation 
  4. Access the best strategic communications and branding (B2B and B2C) support 
  5. Receive exemplary legal advice 

ACI offers solutions for raw material suppliers, manufacturers, brands and others operating in this space.

Benefits of joining ACI